Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05300815 · ClinicalTrials.gov registry record

Identifying Which Adverse Events Associated With Dry Needling Should be Included For Informed Consent: A Modified e-Delphi Study

A clinical trial of Dry Needling, sponsored by Youngstown State University.

Completed
Registry status
39
Enrollment target
1
Study location

NCT05300815 is a study of Dry Needling that has completed, run by Youngstown State University. The registered enrollment target is 39 participants, below the 679-participant average among 4 other Dry Needling trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05300815, a study of Dry Needling, has completed, sponsored by Youngstown State University.

COMPLETED
Registry status
39 participants
Enrollment target
1
Study location

Study Summary

Dry Needling is an intervention that continues to gain widespread interest as a treatment adjunct for various pathological conditions. With the increased use of dry needling in the clinic, there comes a need for additional research to investigate the adverse events associated with the use of dry needling. Informed Consent is a process that is legally required in many states prior to the performance of a treatment intervention like dry needling. It is important therefore to identify which of these adverse events should be included in an informed consent process.

Conditions Studied

Interventions

  • OTHER Delphi Questionaire

Study Locations (1)

Ohio

  • Youngstown State University - Youngstown

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2022-03-02
Est. Completion 2022-07-31

Sponsor

Youngstown State University

19 total trials

What the Registry Record Tells You About NCT05300815

The ClinicalTrials.gov registry entry for NCT05300815 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 679-participant average among 4 other Dry Needling trials with a reported enrollment target (94% lower). The listed sponsor is Youngstown State University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Needling appearing as the primary indexed condition, and to 1 intervention - of which Delphi Questionaire is the first listed.

NCT05300815 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05300815 about?

NCT05300815 is a clinical study titled "Identifying Which Adverse Events Associated With Dry Needling Should be Included For Informed Consent: A Modified e-Delphi Study". Dry Needling is an intervention that continues to gain widespread interest as a treatment adjunct for various pathological conditions. With the increased use of dry needling in the clinic, there comes a need for additional research to investigate the adverse events associated with the use of dry nee...

What is the current status of trial NCT05300815?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2022-03-02. Estimated completion is 2022-07-31.

What conditions does trial NCT05300815 study?

This clinical trial studies the following conditions: Dry Needling.

What interventions are being tested in trial NCT05300815?

The interventions under investigation include: Delphi Questionaire (OTHER).

Who is sponsoring clinical trial NCT05300815?

This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05300815 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dry Needling

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.